Blood advances

Keyphrases

Publications

volume 8, number 9, 2024

Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Rohtesh S Mehta, Effie W Petersdorf, Stephen R Spellman, Stephanie J Lee
Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes. Blood advances 8 (9) (2024)
Constantine S Tam, Phillip A Thompson
BTK inhibitors in CLL: second-generation drugs and beyond. Blood advances 8 (9) (2024)
Allison P Wheeler, Edward L Snyder, Majed Refaai, Claudia S Cohn, Jessica Poisson, Magali J Fontaine, Mary Sehl, Ajay K Nooka, Lynne Uhl, Philip C Spinella, Maly Fenelus, Darla Liles, Thomas Coyle, Joanne Becker, Michael Raymond Jeng, Eric A Gehrie, Bryan R Spencer, Pampee Young, Andrew Johnson, Jennifer J O'Brien, Gary J Schiller, John D Roback, Elizabeth Malynn, Ronald Jackups, Scott T Avecilla, Kathy Liu, Stanley Bentow, Jeanne Varrone, Richard J Benjamin, Laurence M Corash
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components. Blood advances 8 (9) (2024)
Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP. Blood advances 8 (9) (2024)
Lauren E Merz, Duaa AbdelHameid, Dareen M Kanaan, Subrina Farah, Peter Manzo, Nathan T Connell
Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease. Blood advances 8 (9) (2024)
Peiyao Jiang, Fangfang Yu, Xiao Zhou, Huizhong Shi, Qiaomei He, Xian-Min Song
Dissecting causal links between gut microbiota, inflammatory cytokines, and DLBCL: a Mendelian randomization study. Blood advances 8 (9) (2024)
Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP. Blood advances 8 (9) (2024)
Regina M Myers, Kaitlin Devine, Yimei Li, Sophie Lawrence, Allison Barz Leahy, Hongyan Liu, Lauren Vernau, Colleen Callahan, Diane Baniewicz, Stephan Kadauke, Regina McGuire, Gerald B Wertheim, Irina Kulikovskaya, Vanessa E Gonzalez, Joseph A Fraietta, Amanda M DiNofia, Stephen P Hunger, Susan R Rheingold, Richard Aplenc, Carl H June, Stephan A Grupp, Lisa Wray, Shannon L Maude
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia. Blood advances 8 (9) (2024)
Rohtesh S Mehta, Effie W Petersdorf, Stephen R Spellman, Stephanie J Lee
Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Coty Hing Yau Cheung, Chi Keung Cheng, Kam-Tong Leung, Chi Zhang, Chi Yan Ho, Xi Luo, Angel Yuet Fong Kam, Tian Xia, Thomas Shek Kong Wan, Herbert Augustus Pitts, Natalie Pui Ha Chan, Joyce Sin Cheung, Raymond Siu Ming Wong, Xiao-Bing Zhang, Margaret Heung Ling Ng
C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma. Blood advances 8 (9) (2024)
Regina M Myers, Kaitlin Devine, Yimei Li, Sophie Lawrence, Allison Barz Leahy, Hongyan Liu, Lauren Vernau, Colleen Callahan, Diane Baniewicz, Stephan Kadauke, Regina McGuire, Gerald B Wertheim, Irina Kulikovskaya, Vanessa E Gonzalez, Joseph A Fraietta, Amanda M DiNofia, Stephen P Hunger, Susan R Rheingold, Richard Aplenc, Carl H June, Stephan A Grupp, Lisa Wray, Shannon L Maude
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia. Blood advances 8 (9) (2024)
Seiichi Kato, Motoharu Hamada, Akinao Okamoto, Daisuke Yamashita, Hiroaki Miyoshi, Haruto Arai, Akira Satou, Yuka Gion, Yasuharu Sato, Yuta Tsuyuki, Tomoko Miyata-Takata, Katsuyoshi Takata, Naoko Asano, Emiko Takahashi, Koichi Ohshima, Akihiro Tomita, Waki Hosoda, Shigeo Nakamura, Yusuke Okuno
EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome. Blood advances 8 (9) (2024)
Zhihong Zeng, Annelies Roobrouck, Geert Deschamps, Helene Bonnevaux, Stephane Guerif, Veronique De Brabandere, Céline Amara, Eline Dejonckheere, Angela Virone-Oddos, Marielle Chiron, Marina Y Konopleva, Melissa Dullaers
Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile. Blood advances 8 (9) (2024)
Kris Richardson, Jorge J Castillo, Shayna R Sarosiek, Andrew R Branagan, Catherine A Flynn, Kirsten Meid, Joshua N Gustine, Xia Liu, Amanda Kofides, Shirong Liu, Julie L Wolf, Katherine A Kacena, Christopher J Patterson, Maria Luisa Guerrera, Nicholas Tsakmaklis, Steven P Treon, Zachary R Hunter
Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia. Blood advances 8 (9) (2024)
Sara Carrillo De Albornoz, Alisa M Higgins, Dennis Petrie, Adam Irving, Laura Fanning, Robert Weinkove, Philip Crispin, Claire Dendle, Michael Gilbertson, Anna M Johnston, Anastazia Keegan, Dominic Pepperell, Humphrey Pullon, John Reynolds, Tina van Tonder, Judith Trotman, Neil Waters, Cameron Wellard, Helen Weston, C Orla Morrissey, Erica Michelle Wood, Zoe K McQuilten
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies. Blood advances 8 (9) (2024)
Marc Usart, Nils Hansen, Jan Stetka, Tiago Almeida Fonseca, Alexandre Guy, Quentin Kimmerlin, Shivam Rai, Hui Hao-Shen, Julien Roux, Stefan Dirnhofer, Radek C Skoda
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN. Blood advances 8 (9) (2024)
Seiichi Kato, Motoharu Hamada, Akinao Okamoto, Daisuke Yamashita, Hiroaki Miyoshi, Haruto Arai, Akira Satou, Yuka Gion, Yasuharu Sato, Yuta Tsuyuki, Tomoko Miyata-Takata, Katsuyoshi Takata, Naoko Asano, Emiko Takahashi, Koichi Ohshima, Akihiro Tomita, Waki Hosoda, Shigeo Nakamura, Yusuke Okuno
EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome. Blood advances 8 (9) (2024)
Allison P Wheeler, Edward L Snyder, Majed Refaai, Claudia S Cohn, Jessica Poisson, Magali J Fontaine, Mary Sehl, Ajay K Nooka, Lynne Uhl, Philip C Spinella, Maly Fenelus, Darla Liles, Thomas Coyle, Joanne Becker, Michael Raymond Jeng, Eric A Gehrie, Bryan R Spencer, Pampee Young, Andrew Johnson, Jennifer J O'Brien, Gary J Schiller, John D Roback, Elizabeth Malynn, Ronald Jackups, Scott T Avecilla, Kathy Liu, Stanley Bentow, Jeanne Varrone, Richard J Benjamin, Laurence M Corash
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components. Blood advances 8 (9) (2024)
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, Cristine Allmer, Kari G Rabe, Aaron D Norman, Rosalie G Waller, Huihuang Yan, Tao Ma, Timothy G Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A Hanson, Jose F Leis, Wei Ding, Celine M Vachon, Neil E Kay, Christopher C Oakes, Alexander S Parker, Danielle M Brander, J Brice Weinberg, Richard R Furman, Tait D Shanafelt, James R Cerhan, Sameer A Parikh, Esteban Braggio, Susan L Slager
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. Blood advances 8 (9) (2024)
Akihide Nakamura, Masahiro Masuya, Makoto Shinmei, Isao Tawara, Tetsuya Nosaka, Ryoichi Ono
Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia. Blood advances 8 (9) (2024)
Claus-Philipp Maier, Chihab Klose, Christian Martin Seitz, Florian Heubach, Michaela Döring, Richard P Meisel, Friedhelm Schuster, Bernd Gruhn, Frieder Keller, Armin Rabsteyn, Anne-Marie Arendt, Germano Amorelli, Thomas Eichholz, Tobias Feuchtinger, Holger Martinius, Stefan Nierkens, Rouwen Teltschik, Johannes Hubertus Schulte, Claudia Lengerke, Rupert Handgretinger, Peter Lang
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT. Blood advances 8 (9) (2024)
Marc Usart, Nils Hansen, Jan Stetka, Tiago Almeida Fonseca, Alexandre Guy, Quentin Kimmerlin, Shivam Rai, Hui Hao-Shen, Julien Roux, Stefan Dirnhofer, Radek C Skoda
The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN. Blood advances 8 (9) (2024)
Zachariah DeFilipp, Ashish V Damania, Haesook T Kim, Chia-Chi Chang, Areej El-Jawahri, Steven L McAfee, Aj S Bottoms, Vesselina Toncheva, Melissa M Smith, Maria Dolaher, Lindsey Perry, Meghan White, Brittany Diana, Sheila Connolly, Bimalangshu R Dey, Matthew J Frigault, Richard A Newcomb, Paul V O'Donnell, Thomas R Spitzer, Michael K Mansour, Daniela Weber, Nadim J Ajami, Elizabeth Hohmann, Robert R Jenq, Yi-Bin Chen
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract. Blood advances 8 (9) (2024)
Kris Richardson, Jorge J Castillo, Shayna R Sarosiek, Andrew R Branagan, Catherine A Flynn, Kirsten Meid, Joshua N Gustine, Xia Liu, Amanda Kofides, Shirong Liu, Julie L Wolf, Katherine A Kacena, Christopher J Patterson, Maria Luisa Guerrera, Nicholas Tsakmaklis, Steven P Treon, Zachary R Hunter
Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia. Blood advances 8 (9) (2024)
Constantine S Tam, Phillip A Thompson
BTK inhibitors in CLL: second-generation drugs and beyond. Blood advances 8 (9) (2024)
Akihide Nakamura, Masahiro Masuya, Makoto Shinmei, Isao Tawara, Tetsuya Nosaka, Ryoichi Ono
Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia. Blood advances 8 (9) (2024)
Sara Carrillo De Albornoz, Alisa M Higgins, Dennis Petrie, Adam Irving, Laura Fanning, Robert Weinkove, Philip Crispin, Claire Dendle, Michael Gilbertson, Anna M Johnston, Anastazia Keegan, Dominic Pepperell, Humphrey Pullon, John Reynolds, Tina van Tonder, Judith Trotman, Neil Waters, Cameron Wellard, Helen Weston, C Orla Morrissey, Erica Michelle Wood, Zoe K McQuilten
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies. Blood advances 8 (9) (2024)
Kevin Robert Reyes, Yen-Chun Liu, Chiung-Yu Huang, Rahul Banerjee, Thomas Martin, Sandy W Wong, Jeffrey L Wolf, Shagun Arora, Nina Shah, Ajai Chari, Alfred Chung
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma. Blood advances 8 (9) (2024)
Shanmuganathan Chandrakasan, Michael B Jordan, Ashley A Baker, Edward M Behrens, Deepika Bhatla, May Chien, Olive S Eckstein, Michael M Henry, Michelle L Hermiston, Ashley P Hinson, Jennifer W Leiding, Abiola Oladapo, Sachit A Patel, Priti Pednekar, Anish K Ray, Blachy J Dávila Saldaña, Susmita N Sarangi, Kelly J Walkovich, John D Yee, Adi Zoref-Lorenz, Carl E Allen
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood advances 8 (9) (2024)
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, Cristine Allmer, Kari G Rabe, Aaron D Norman, Rosalie G Waller, Huihuang Yan, Tao Ma, Timothy G Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A Hanson, Jose F Leis, Wei Ding, Celine M Vachon, Neil E Kay, Christopher C Oakes, Alexander S Parker, Danielle M Brander, J Brice Weinberg, Richard R Furman, Tait D Shanafelt, James R Cerhan, Sameer A Parikh, Esteban Braggio, Susan L Slager
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. Blood advances 8 (9) (2024)
Nilesh Pandey, Harpreet Kaur, Mehulkumar Ramanlal Chorawala, Sumit Kumar Anand, Lakshmi Chandaluri, Megan E Butler, Richa Aishwarya, Shiva J Gaddam, Xinggui Shen, Mabruka Alfaidi, Jian Wang, Xiaolu Xhang, Kavitha Beedupalli, Md Shenuarin Bhuiyan, Mohammad Alfrad Nobel Bhuiyan, Prabandh Buchhanolla, Prashant Rai, Rahul Shah, Himanshu Chokhawala, J. Dedrick Jordan, Tarek Magdy, Anthony Wayne Orr, Karen Y Stokes, Oren Rom, Nirav Dhanesha
Interactions between integrin α9β1 and VCAM-1 promote neutrophil hyperactivation and mediate poststroke DVT. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Claus-Philipp Maier, Chihab Klose, Christian Martin Seitz, Florian Heubach, Michaela Döring, Richard P Meisel, Friedhelm Schuster, Bernd Gruhn, Frieder Keller, Armin Rabsteyn, Anne-Marie Arendt, Germano Amorelli, Thomas Eichholz, Tobias Feuchtinger, Holger Martinius, Stefan Nierkens, Rouwen Teltschik, Johannes Hubertus Schulte, Claudia Lengerke, Rupert Handgretinger, Peter Lang
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCT. Blood advances 8 (9) (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy? Blood advances 8 (9) (2024)
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti, Benjamin S Braun, Danielle C Kirkey, Leila Robinson, Jack H Peplinksi, Beverly Lange, Todd M Cooper, Alan S Gamis, E Anders Kolb, Richard Aplenc, Jessica A Pollard, Todd A Alonzo, Soheil Meshinchi
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood advances 8 (9) (2024)
Nilesh Pandey, Harpreet Kaur, Mehulkumar Ramanlal Chorawala, Sumit Kumar Anand, Lakshmi Chandaluri, Megan E Butler, Richa Aishwarya, Shiva J Gaddam, Xinggui Shen, Mabruka Alfaidi, Jian Wang, Xiaolu Xhang, Kavitha Beedupalli, Md Shenuarin Bhuiyan, Mohammad Alfrad Nobel Bhuiyan, Prabandh Buchhanolla, Prashant Rai, Rahul Shah, Himanshu Chokhawala, J. Dedrick Jordan, Tarek Magdy, Anthony Wayne Orr, Karen Y Stokes, Oren Rom, Nirav Dhanesha
Interactions between integrin α9β1 and VCAM-1 promote neutrophil hyperactivation and mediate poststroke DVT. Blood advances 8 (9) (2024)
Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A Tormey, Harlan M Krumholz, Adam Cuker, George Goshua
Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood advances 8 (9) (2024)
Zachariah DeFilipp, Ashish V Damania, Haesook T Kim, Chia-Chi Chang, Areej El-Jawahri, Steven L McAfee, Aj S Bottoms, Vesselina Toncheva, Melissa M Smith, Maria Dolaher, Lindsey Perry, Meghan White, Brittany Diana, Sheila Connolly, Bimalangshu R Dey, Matthew J Frigault, Richard A Newcomb, Paul V O'Donnell, Thomas R Spitzer, Michael K Mansour, Daniela Weber, Nadim J Ajami, Elizabeth Hohmann, Robert R Jenq, Yi-Bin Chen
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract. Blood advances 8 (9) (2024)
Cecily Allen, Satoko Ito, Ayesha Butt, Adriana Purcell, Rhys Richmond, Christopher A Tormey, Harlan M Krumholz, Adam Cuker, George Goshua
Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood advances 8 (9) (2024)
Shanmuganathan Chandrakasan, Michael B Jordan, Ashley A Baker, Edward M Behrens, Deepika Bhatla, May Chien, Olive S Eckstein, Michael M Henry, Michelle L Hermiston, Ashley P Hinson, Jennifer W Leiding, Abiola Oladapo, Sachit A Patel, Priti Pednekar, Anish K Ray, Blachy J Dávila Saldaña, Susmita N Sarangi, Kelly J Walkovich, John D Yee, Adi Zoref-Lorenz, Carl E Allen
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood advances 8 (9) (2024)
Kevin Robert Reyes, Yen-Chun Liu, Chiung-Yu Huang, Rahul Banerjee, Thomas Martin, Sandy W Wong, Jeffrey L Wolf, Shagun Arora, Nina Shah, Ajai Chari, Alfred Chung
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma. Blood advances 8 (9) (2024)
Lauren E Merz, Duaa AbdelHameid, Dareen M Kanaan, Subrina Farah, Peter Manzo, Nathan T Connell
Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease. Blood advances 8 (9) (2024)
Peiyao Jiang, Fangfang Yu, Xiao Zhou, Huizhong Shi, Qiaomei He, Xian-Min Song
Dissecting causal links between gut microbiota, inflammatory cytokines, and DLBCL: a Mendelian randomization study. Blood advances 8 (9) (2024)
Coty Hing Yau Cheung, Chi Keung Cheng, Kam-Tong Leung, Chi Zhang, Chi Yan Ho, Xi Luo, Angel Yuet Fong Kam, Tian Xia, Thomas Shek Kong Wan, Herbert Augustus Pitts, Natalie Pui Ha Chan, Joyce Sin Cheung, Raymond Siu Ming Wong, Xiao-Bing Zhang, Margaret Heung Ling Ng
C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma. Blood advances 8 (9) (2024)
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, Jenny L Smith, Amanda Leonti, Benjamin S Braun, Danielle C Kirkey, Leila Robinson, Jack H Peplinksi, Beverly Lange, Todd M Cooper, Alan S Gamis, E Anders Kolb, Richard Aplenc, Jessica A Pollard, Todd A Alonzo, Soheil Meshinchi
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Blood advances 8 (9) (2024)
Zhihong Zeng, Annelies Roobrouck, Geert Deschamps, Helene Bonnevaux, Stephane Guerif, Veronique De Brabandere, Céline Amara, Eline Dejonckheere, Angela Virone-Oddos, Marielle Chiron, Marina Y Konopleva, Melissa Dullaers
Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile. Blood advances 8 (9) (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy? Blood advances 8 (9) (2024)